Maternal Morbidity and Outcomes Associated with Placenta Previa and Placenta Accreta Spectrum Disorders
International Journal of Pharmaceutical Quality Assurance · 10.07.2026 · 16 (11)
DOI: 10.25258/ijpqa.16.11.122 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 10.07.2026. Verfasst von Rukhsar Quasmi und 2 weiteren Autor:innen.
Abstract (Originalsprache)
.
Zitieren
APA
Quasmi, R., Kumari, S., & Pathak, A. (2026). Maternal Morbidity and Outcomes Associated with Placenta Previa and Placenta Accreta Spectrum Disorders. International Journal of Pharmaceutical Quality Assurance, 16(11). https://doi.org/10.25258/ijpqa.16.11.122
Vancouver
Quasmi R, Kumari S, Pathak A. Maternal Morbidity and Outcomes Associated with Placenta Previa and Placenta Accreta Spectrum Disorders. International Journal of Pharmaceutical Quality Assurance. 2026;16(11). doi:10.25258/ijpqa.16.11.122
BibTeX
@article{Quasmi2026,
author = {Quasmi, Rukhsar and Kumari, Suruchi and Pathak, Anita},
title = {Maternal Morbidity and Outcomes Associated with Placenta Previa and Placenta Accreta Spectrum Disorders},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {16},
number = {11},
doi = {10.25258/ijpqa.16.11.122}
}
EUVIMED